(a) (1) All proceedings and records related to a professional review activity, including all meetings, interviews, reports, statements, minutes, memoranda, notes, investigative compilations and the contents thereof, and all other information and materials relating to professional review activities shall be confidential and are included within the categories of records and proceedings that are exempt from discovery and disclosure pursuant to § 16-46-105(a)(1) and § 20-9-503.
(2) Nothing in this subchapter shall affect the admissibility in evidence in any action or proceeding of the medical records of any patient.
(b) Nothing in this subchapter shall be construed to abrogate the immunities or confidentiality provisions of the Health Care Quality Improvement Act of 1986, 42 U.S.C. § 11101 et seq., or § 16-46-105, § 17-1-102, or § 20-9-501 et seq.
Section: Previous 20-9-1302 20-9-1303 20-9-1304 20-9-1305 20-9-1306 20-9-1307 20-9-1308Last modified: November 15, 2016